National Trends in 30-Day Readmission Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.

ABSTRACT:

Importance

As the incidence of oropharyngeal squamous cell carcinoma (OPSCC) continues to rise in the US, an increasing number of patients are being treated with transoral robotic surgery (TORS). Readmission following surgery can potentially delay initiation of adjuvant treatment and affect survival outcomes.

Objective

To identify risk factors for 30-day postoperative readmission in patients undergoing TORS for OPSCC.

Design, setting, and participants

This retrospective, population-based cohort study used data from the Nationwide Readmissions Database from 2010 to 2017. All patients undergoing TORS for OPSCC were identified using International Classification of Diseases codes and included. Exclusion criteria were age younger than 18 years or incomplete information reg

SUBMITTER: Nyirjesy SC 

PROVIDER: S-EPMC10853828 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature